ArticleInvestigational new drugs2017

Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.

Sagar Shelake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.